NorthStar Medical technologies, Beloit, Wis., inked a $37-million cooperative agreement with the National Nuclear Security Administration to produce the medical isotope Molybdenum-99, the semi-autonomous Department of Energy agency announced Aug. 27.
NorthStar,…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.





